Single product biotech, blood substitute "Polyheme" HUGH potential! Submitted requist for fast track with FDA, expected response in OCT; Top line results of phase III trial by end of year; BLA application first half of 2007. This stock is on reg SHO threshold list and highly manipulated!!!! However, shares are now very tight, so there is a possablity of a short squeeze in progress.

Google "Polyheme" or go to Northfield Labs website. This is a all or nothing stock, but I believe the product works and thus this is a very good investment, not a trade. Do your research!